4.87
price up icon2.96%   0.14
 
loading
前日終値:
$4.73
開ける:
$5.3177
24時間の取引高:
809
Relative Volume:
0.08
時価総額:
$229.91M
収益:
$27,600
当期純損益:
$-36.04M
株価収益率:
-6.1119
EPS:
-0.7968
ネットキャッシュフロー:
$-1.66M
1週間 パフォーマンス:
+2.96%
1か月 パフォーマンス:
+18.78%
6か月 パフォーマンス:
+62.33%
1年 パフォーマンス:
-9.73%
1日の値動き範囲:
Value
$4.87
$5.3177
1週間の範囲:
Value
$4.50
$5.3177
52週間の値動き範囲:
Value
$2.76
$6.00

Nanobiotix Adr Stock (NBTX) Company Profile

Name
名前
Nanobiotix Adr
Name
セクター
Healthcare (1160)
Name
電話
-
Name
住所
-
Name
職員
108
Name
Twitter
Name
次回の収益日
2025-04-02
Name
最新のSEC提出書
Name
NBTX's Discussions on Twitter

NBTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NBTX
Nanobiotix Adr
4.87 229.91M 27,600 -36.04M -1.66M -0.7968
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-28 開始されました Guggenheim Buy
2023-12-08 開始されました Leerink Partners Outperform
2021-01-06 開始されました Evercore ISI Outperform

Nanobiotix Adr (NBTX) 最新ニュース

pulisher
Jun 05, 2025

Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks

Jun 05, 2025
pulisher
May 07, 2025

symbol__ Stock Quote Price and Forecast - CNN

May 07, 2025
pulisher
Apr 30, 2025

Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast - GlobeNewswire Inc.

Apr 30, 2025
pulisher
Apr 04, 2025

Guggenheim cuts Nanobiotix stock target to $8, maintains buy - Investing.com

Apr 04, 2025
pulisher
Apr 03, 2025

Nanobiotix SA ADR Reports 2024 Financial Results - TipRanks

Apr 03, 2025
pulisher
Jan 22, 2025

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study - MSN

Jan 22, 2025
pulisher
Aug 09, 2024

Mexico Chitosan Market Size & Outlook, 2022-2030 - Grand View Research

Aug 09, 2024
pulisher
Jul 31, 2024

Latin America Chitosan Market Size & Outlook, 2022-2030 - Grand View Research

Jul 31, 2024
pulisher
Jul 31, 2024

Middle East & Africa Chitosan Market Size & Outlook, 2030 - Grand View Research

Jul 31, 2024
pulisher
Jul 28, 2024

The United States Chitosan Market Size & Outlook, 2030 - Grand View Research

Jul 28, 2024
pulisher
Jun 27, 2024

China Chitosan Market Size & Outlook, 2022-2030 - Grand View Research

Jun 27, 2024
pulisher
Jun 27, 2024

Japan Chitosan Market Size & Outlook, 2022-2030 - Grand View Research

Jun 27, 2024
pulisher
May 14, 2024

Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study - TipRanks

May 14, 2024
pulisher
May 05, 2023

Nanobiotix (NBTX) Stock Soared 107.9% on a Global Pharma Deal - AskTraders.com

May 05, 2023
pulisher
Dec 11, 2020

NBTX News Today | Why did Nanobiotix stock go down today? - MarketBeat

Dec 11, 2020
pulisher
Dec 11, 2020

Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat

Dec 11, 2020

Nanobiotix Adr (NBTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):